Finance

Lists
Q2 2027 earnings • released • Revenue beat +0.08%
See results
3401:TYO
Teijin Ltd
¥1,873.00
+16.70%
(+268.00) 1D
Nov 5, 3:30:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 3401...
Open
¥1,658
High
¥1,878
Low
¥1,636
Mkt. cap
380.13B
Avg. vol.
634.53K
Volume
3.98M
Dividend
2.67%
Quarterly dividend
¥13
Ex-dividend date
Sep 29, 2026
52-wk high
¥1,878
52-wk low
¥1,202
EPS
-¥219
Shares outstanding
191.79M
No. of employees
16K
Open
¥1,658
High
¥1,878
Low
¥1,636
Mkt. cap
380.13B
Avg. vol.
634.53K
Volume
3.98M
Dividend
2.67%
Quarterly dividend
¥13
Ex-dividend date
Sep 29, 2026
52-wk high
¥1,878
52-wk low
¥1,202
EPS
-¥219
Shares outstanding
191.79M
No. of employees
16K
News stories
From web sources and news partners
Profile
Teijin Limited is a Japanese chemical, pharmaceutical and information technology company. Its main fields of operation are high-performance fibers such as aramid, carbon fibers & composites, healthcare, films, resin & plastic processing, polyester fibers, products converting and IT products. The company is listed on the first section of the Tokyo Stock Exchange and is a constituent of the Nikkei 225 stock index. As of March 2014, the Teijin Group comprises 151 companies, 56 in Japan and 95 overseas. Teijin is a member of the Mitsubishi UFJ Financial Group keiretsu. Wikipedia
About Teijin Ltd
CEOJun Suzuki | Akimoto Uchikawa
Employees15.7K
FoundedJun 17, 1918
Headquarters-
SectorCommodity chemical
Industry-
Websiteteijin.com
Last report
Just released
Today, 7:00 AM
Fiscal period
Q2 2027
- / -
Revenue / Est. (JPY)
217.62B / 217.45B
Fiscal Q2 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
207.93B
208.84B
213.31B
221.94B
Cost of goods sold
199.31B
151.75B
214.65B
163.32B
Cost of revenue
199.31B
151.75B
214.65B
163.32B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
54.35B
48.52B
82.60B
48.85B
Operating expense
65.00B
48.36B
70.37B
-1.34B
Total operating expenses
264.30B
200.11B
285.02B
161.98B
Operating income
-56.38B
8.72B
-71.71B
59.96B
Other non operating income
1.00M
-1.00M
-924.00M
-
EBT including unusual items
-55.82B
-115.00M
-18.18B
59.83B
EBT excluding unusual items
-55.82B
8.30B
-72.95B
59.83B
Income tax expense
-1.66B
4.06B
10.83B
14.80B
Effective tax rate
2.98%
-3,533.91%
-59.56%
24.73%
Other operating expenses
10.65B
-155.00M
-12.23B
-50.19B
Net income
-54.10B
-4.14B
-29.03B
45.11B
Net profit margin
-26.02%
-1.98%
-13.61%
20.32%
Earnings per share
-
-
-
-
Interest and investment income
1.00B
808.00M
1.68B
1.38B
Interest expense
-1.36B
-1.47B
-
-1.78B
Net interest expenses
-357.00M
-664.00M
1.68B
-400.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
-40.32B
23.50B
-57.54B
72.34B
Gain or loss from assets sale
50.64B
10.92B
77.54B
-4.86B
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps